Journal Article DZNE-2020-06318

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2018
Elsevier Amsterdam [u.a.]

Alzheimer's and dementia 14(6), 707-722 () [10.1016/j.jalz.2017.11.012]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Identifying circulating metabolites that are associated with cognition and dementia may improve our understanding of the pathogenesis of dementia and provide crucial readouts for preventive and therapeutic interventions.We studied 299 metabolites in relation to cognition (general cognitive ability) in two discovery cohorts (N total = 5658). Metabolites significantly associated with cognition after adjusting for multiple testing were replicated in four independent cohorts (N total = 6652), and the associations with dementia and Alzheimer's disease (N = 25,872) and lifestyle factors (N = 5168) were examined.We discovered and replicated 15 metabolites associated with cognition including subfractions of high-density lipoprotein, docosahexaenoic acid, ornithine, glutamine, and glycoprotein acetyls. These associations were independent of classical risk factors including high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, glucose, and apolipoprotein E (APOE) genotypes. Six of the cognition-associated metabolites were related to the risk of dementia and lifestyle factors.Circulating metabolites were consistently associated with cognition, dementia, and lifestyle factors, opening new avenues for prevention of cognitive decline and dementia.

Keyword(s): Adult (MeSH) ; Aged (MeSH) ; Alzheimer Disease: metabolism (MeSH) ; Biomarkers: metabolism (MeSH) ; Cognitive Dysfunction: metabolism (MeSH) ; Cohort Studies (MeSH) ; Dementia: metabolism (MeSH) ; Female (MeSH) ; Humans (MeSH) ; Life Style (MeSH) ; Male (MeSH) ; Middle Aged (MeSH) ; Reproducibility of Results (MeSH) ; Risk Factors (MeSH) ; Biomarkers

Classification:

Contributing Institute(s):
  1. Neuropsychology (AG Wagner)
  2. U Clinical Researchers - Bonn (U Clinical Researchers - Bonn)
  3. Biomarkers of Dementia in the General Population (AG Grabe)
Research Program(s):
  1. 344 - Clinical and Health Care Research (POF3-344) (POF3-344)

Appears in the scientific report 2018
Database coverage:
Medline ; Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0 ; OpenAccess ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; IF >= 15 ; JCR ; SCOPUS ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Institute Collections > BN DZNE > BN DZNE-U Clinical Researchers \- Bonn
Document types > Articles > Journal Article
Institute Collections > ROS DZNE > ROS DZNE-AG Grabe
Institute Collections > BN DZNE > BN DZNE-AG Wagner
Full Text Collection
Public records
Publications Database


Linked articles:

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article (Erratum/Correction)  ;  ;  ;
Erratum to 'Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies' [Alzheimer's & Dementia 2018;14:707-22.].
Alzheimer's and dementia 15(2), 319-319 () [10.1016/j.jalz.2019.01.002] OpenAccess  Download fulltext Files BibTeX | EndNote: XML, Text | RIS


 Record created 2020-02-18, last modified 2024-03-21


OpenAccess:
Download fulltext PDF Download fulltext PDF (PDFA)
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)